2017 American Transplant Congress
Outcomes of Kidney Transplantation After Primary, Repeat and Kidney After Nonrenal Solid Organ Transplantation: 10 Years UNOS Database Analysis.
Introduction: The aim of the study is to evaluate patient and kidney allograft survivals in primary, repeat, and kidney after nonrenal organ transplantation using national…2017 American Transplant Congress
Outcome of ABO-Incompatible Kidney Transplantation After Stratified Desensitization.
Background. Plasmapheresis for antibody removal and rituximab for antibody production suppression are performed for desensitization against ABO-incompatible kidney transplantation. We evaluated clinical outcome for optimizing…2017 American Transplant Congress
Prevalence and Clinical Outcomes in Kidney Transplant Patients with Viral and Fungal Opportunistic Infections and Malignancy.
Montefiore Medical Center, Bronx
Opportunistic infections and malignancy after kidney transplant (KTX) are associated with increased morbidity and mortality. We aimed to assess predictors and clinical outcomes in patients…2017 American Transplant Congress
Clinical and Molecular Significance of Microvascular Inflammation Negative Transplant Glomerulopathy.
Transplant glomerulopathy (TGP) with donor specific antibodies (DSA) and microvascular inflammation (MVI) is due to chronic antibody mediated rejection (CAMR). We reported previously that intragraft…2017 American Transplant Congress
Role of HMG CoA Reductase Inhibitors on Time to Development of Chronic Lung Allograft Dysfunction Post-Lung Transplant.
Duke University Hospital, Durham, NC
Purpose: Five-year survival after lung transplant (LT) is approximately 55%. Chronic lung allograft dysfunction (CLAD) is a primary contributor to this reduced survival post-LT. Options…2017 American Transplant Congress
Subpopulations of Peripheral Blood Monocytes in Kidney Allograft Recipients.
Human peripheral blood monocytes may be divided into different subsets based on the expression of membrane antigens. Our pilot data suggested that after the kidney…2017 American Transplant Congress
Comparison of Long Term Survival Outcomes for Everolimus (EVR) vs. Mycophenolic Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant.
In the US, MPA in combination with calcineurin inhibitors (CNI, tacrolimus [TAC] or cyclosporine A [CsA]) is the most commonly used maintenance immunosuppressive therapy post…2017 American Transplant Congress
Rapid Deterioration of Pre-Transplant Kidney Function Requiring Dialysis Is a Prognostic Factor in Liver Transplant Alone.
Aim: Etiologies of acute kidney injury before liver transplant extend beyond hepatorenal syndrome (ie infection, gastrointestinal bleeding) and therefore, may not be resolved by liver…2017 American Transplant Congress
Assessment of the Risk Index for Living Donor Kidney Transplantation (LKDPI) in a European Cohort.
Nephrology, Charité Universitaetsmedizin, Berlin, Germany
Introduction: Recently, a risk index for living donor kidney transplantation (LKDPI) was proposed (Massie et al. AJT 2016) to compare living donor kidneys (LDK) to…2017 American Transplant Congress
The Use of Very High KDPI Kidneys in Elderly Kidney Transplant Recipients – Discarded in the U.S. but Successfully Transplanted in Europe.
Nephrology, Charité Berlin, Berlin, Germany
Background: Very limited data exist on long-term outcomes of very high KDPI kidneys in elderly (≥65 years) kidney transplant recipients (KTR). Discard rates of donor…
- « Previous Page
- 1
- …
- 75
- 76
- 77
- 78
- 79
- …
- 113
- Next Page »